PMID- 2249017 OWN - NLM STAT- MEDLINE DCOM- 19910114 LR - 20091111 IS - 0007-4551 (Print) IS - 0007-4551 (Linking) VI - 77 IP - 10 DP - 1990 TI - [Prognostic value of thymidine kinase in cancer of the breast]. PG - 973-83 AB - We have measured by a radioenzymatic assay the thymidine kinase in the cytosol of 182 primary infiltrating breast cancers. Maximal follow-up is 95 months. Thymidine kinase was found to be related to SBR grade, tumour size and absence of oestradiol receptors (RE). Univariate analysis has pointed out a significant linkage between overall or metastase free survival and thymidine kinase, using a cut-off level of 80 mU/mg protein which is the most discriminating value. Thymidine kinase appeared to be particularly useful in lymph-node-positive, RE-negative and grade 3 patients. Multivariate analysis of the overall survival and of the metastase free survival (Cox model) revealed that they were strongly related to thymidine kinase status. FAU - Romain, S AU - Romain S AD - Laboratoire d'oncologie biologique-biopathologie tissulaire, faculte de medecine de Marseille-secteur nord, France. FAU - Javre, J L AU - Javre JL FAU - Samperez, S AU - Samperez S FAU - Jouan, P AU - Jouan P FAU - Bressac, C AU - Bressac C FAU - Varette, I AU - Varette I FAU - Brandone, H AU - Brandone H FAU - Martin, P M AU - Martin PM LA - fre PT - English Abstract PT - Journal Article TT - Valeur pronostique de la thymidine kinase dans le cancer du sein. PL - France TA - Bull Cancer JT - Bulletin du cancer JID - 0072416 RN - 0 (Receptors, Estradiol) RN - 0 (Receptors, Progesterone) RN - EC 2.7.1.21 (Thymidine Kinase) SB - IM MH - Axilla MH - Breast Neoplasms/*enzymology/mortality/pathology MH - Cytosol/enzymology MH - Female MH - Follow-Up Studies MH - Humans MH - Lymphatic Metastasis MH - Middle Aged MH - Neoplasm Staging MH - Prognosis MH - Receptors, Estradiol/analysis MH - Receptors, Progesterone/analysis MH - Survival Analysis MH - Thymidine Kinase/analysis/*metabolism EDAT- 1990/01/01 00:00 MHDA- 1990/01/01 00:01 CRDT- 1990/01/01 00:00 PHST- 1990/01/01 00:00 [pubmed] PHST- 1990/01/01 00:01 [medline] PHST- 1990/01/01 00:00 [entrez] PST - ppublish SO - Bull Cancer. 1990;77(10):973-83.